Patent US3705575A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5814014A Expired / Lapsed US ⏱️ 0.0 years remaining

Techniques of treating neurodegenerative disorders by brain infusion

Assignee: Medtronic Inc
•
Filing: 1997-07-29
•
Granted: 1998-09-29
•
Expires: 2017-07-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Techniques for infusing drugs into the brain to treat neurodegenerative disorders by system of an implantable pump and catheter. The drugs are capable of altering the level of excitation of neruons in the brain. A sensor is used to detect an attribute of the nervous system which reflects the hyperexcitation of the nerve cells projecting onto the degenerating nerve cells. A microprocessor algorithm analyzes the output from the sensor in order to regulate the amount of drug delivered to the brain.

Inventors

  • 👤 Dennis D. Elsberry
  • 👤 Mark T. Rise

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 14:51
CPC Classifications
A; A61; A61M; A61M5/00; A61M5/14; A61M5/142; A61M5/14244; A61M5/14276; A61M5/168; A61M5/172; A61M5/1723; A61M2210/00; A61M2210/06; A61M2210/0693

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 118 words
A system for treating a neurodegenerative disorder resulting in degenerating neurons forming part of a central nervous system comprising in combination: an implantable pump; a catheter having a proximal end coupled to said pump and a discharge portion for infusing into a predetermined infusion site in said central nervous system a therapeutic dosage of at least one drugs capable of altering the level of excitation of neurons in said brain related to a degenerating neurons; a sensor for generating a signal related to an attribute of said nervous system which indicates the hyperexcitation of said degenerating neurons or of neurons related to said degenerating neurons; and control means responsive to said sensor signal for regulating said therapeutic dosage.
Claim 2
Independent Claim 118 words
A system for treating a neurodegenerative disorder resulting in degenerating neurons forming part of a central nervous system comprising in combination: an implantable pump; a catheter having a proximal end coupled to said pump and a discharge portion for infusing into a predetermined infusion site in said central nervous system a therapeutic dosage of at least one drugs capable of altering the level of excitation of neurons in said brain related to a degenerating neurons; a sensor for generating a signal related to an attribute of said nervous system which indicates the hyperexcitation of said degenerating neurons or of neurons related to said degenerating neurons; and control means responsive to said sensor signal for regulating said therapeutic dosage.
Claim 3
Dependent Claim 24 words
A system, as claimed in claim 1, wherein said sensor comprises means for detecting changes in electromagnetic waves generated by muscle or nerve tissue.
Claim 4
Dependent Claim 26 words
A system, as claimed in claim 1, wherein said sensor comprises means for detecting the extent of the hyperexcitation of the glutamatergic neurons of said brain.
Claim 5
Dependent Claim 14 words
A system, as claimed in claim 1, wherein said control means comprises a microprocessor.
Claim 6
Dependent Claim 15 words
A system, as claimed in claim 1, wherein said control means comprises an electrical filter.
Claim 7
Dependent Claim 40 words
A system, as claimed in claim 1, wherein said control means comprises means for increasing said therapeutic dosage in response to an increase in said hyperexcitation and for decreasing said therapeutic dosage in respone to a decrease in said hyperexcitation.
Claim 8
Dependent Claim 31 words
A system, as claimed in claim 1, wherein said predetermined infusion site is selected from the group consisting of the brain, the cerebral ventricle, the subdural space or the intrathecal space.

References Cited (Backward Citations)

US4146029A Cited
US3957036A Cited
US4256437A Cited
US4576556A Cited
US4692147A Cited
US5011472A Cited
US5474547A Cited
US5713888A Cited
US5293879A Cited
WO1994001166A1 Cited
US5713858A Cited
US5735814A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2001-09-28 2002-03-30 2002-09-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2005-09-28 2006-03-30 2006-09-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2009-09-28 2010-03-30 2010-09-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag